These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 3535511)

  • 1. Diabetes: controlling the insulin balance. Intensive conventional insulin therapy.
    Haire-Joshu D; Flavin K; Santiago JV
    Am J Nurs; 1986 Nov; 86(11):1251-5. PubMed ID: 3535511
    [No Abstract]   [Full Text] [Related]  

  • 2. A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes.
    Hassan K; Rodriguez LM; Johnson SE; Tadlock S; Heptulla RA
    Pediatrics; 2008 Mar; 121(3):e466-72. PubMed ID: 18299307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Conventional insulin treatment and treatment using multiple injections in diabetes mellitus].
    Hildebrandt R; Madsbad S
    Ugeskr Laeger; 1989 Jul; 151(31):1960-7. PubMed ID: 2672490
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postprandial rather than preprandial glucose levels should be used for adjustment of rapid-acting insulins.
    Bell DS; Ovalle F; Shadmany S
    Endocr Pract; 2000; 6(6):477-8. PubMed ID: 11155223
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of juvenile diabetes mellitus: usefulness of 24-hour fractional quantitative urine glucose.
    Forman BH; Goldstein PS; Genel M
    Pediatrics; 1974 Feb; 53(2):257-63. PubMed ID: 4812010
    [No Abstract]   [Full Text] [Related]  

  • 6. [Insulin treatment in children].
    Birkebaek NH; Hertz B; Olsen BS
    Ugeskr Laeger; 2009 Jun; 171(23):1919-22. PubMed ID: 19500514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn therapy for newly diagnosed type 1 diabetes.
    Al Shamsi AM
    Pediatrics; 2008 Sep; 122(3):675-6; author reply 676. PubMed ID: 18762540
    [No Abstract]   [Full Text] [Related]  

  • 8. Clinical strategies for controlling peaks and valleys: type 1 diabetes.
    Bolli GB
    Int J Clin Pract Suppl; 2002 Jul; (129):65-74. PubMed ID: 12166610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Injection of acidic or neutral insulin and pain: a single-center, prospective, controlled, noninterventional study in pediatric patients with type 1 diabetes mellitus.
    Karges B; Muche R; Riegger I; Moritz M; Heinze E; Debatin KM; Wabitsch M; Karges W
    Clin Ther; 2006 Dec; 28(12):2094-101. PubMed ID: 17296465
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New insulin with uniform action. Hazards of blood sugar variations minimized].
    MMW Fortschr Med; 2003 Oct; 145(40):55. PubMed ID: 14603609
    [No Abstract]   [Full Text] [Related]  

  • 11. [Comparative evaluation of the effectiveness of insulin preparations "Lente GP" and "Insulong" in type 1 diabetes mellitus].
    Kudriakova SV; Belovanova IM; Romanovskaia GA; Kasymov UA
    Sov Med; 1991; (9):75-7. PubMed ID: 1798933
    [No Abstract]   [Full Text] [Related]  

  • 12. Rationale for using combinations of short-acting insulin analogue and NPH insulin at mealtime in the treatment of type 1 diabetes mellitus.
    Bolli GB
    J Pediatr Endocrinol Metab; 1999; 12 Suppl 3():737-44. PubMed ID: 10626264
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of type I diabetics with a combination of Superdep + DEP + NZI and an adjustment of the insulin dosage by means of a Biostator].
    Kábrt J; Masek Z; Páv J; Skrha J; Hodinár A
    Vnitr Lek; 1986 Apr; 32(4):373-8. PubMed ID: 3523974
    [No Abstract]   [Full Text] [Related]  

  • 14. Ultralente and multiple shots of regular insulin.
    Sindler B; Mersey JH
    Md Med J; 1992 Dec; 41(12):1131. PubMed ID: 1291838
    [No Abstract]   [Full Text] [Related]  

  • 15. Glucose evaluation trial for remission (GETREM) in type 1 diabetes: a European multicentre study.
    Pozzilli P; Manfrini S; Buzzetti R; Lampeter E; Leeuw ID; Iafusco D; Prisco M; Ionescu-Tirgoviste C; Kolouskovà S; Linn T; Ludvigsson J; Madàcsy L; Mrozikiewicz AS; Mrozikiewicz PM; Podar T; Vavrinec J; Vialettes B; Visalli N; Yilmaz T; Browne PD;
    Diabetes Res Clin Pract; 2005 Jun; 68(3):258-64. PubMed ID: 15936469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proportional dose-response relationship and lower within-patient variability of insulin detemir and NPH insulin in subjects with type 1 diabetes mellitus.
    Wutte A; Plank J; Bodenlenz M; Magnes C; Regittnig W; Sinner F; Rønn B; Zdravkovic M; Pieber TR
    Exp Clin Endocrinol Diabetes; 2007 Jul; 115(7):461-7. PubMed ID: 17647145
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Home blood glucose monitoring in insulin-dependent diabetic children.
    Tan SH; Lee BW; Wong HB
    Turk J Pediatr; 1983; 25(1):25-33. PubMed ID: 6649074
    [No Abstract]   [Full Text] [Related]  

  • 18. Selecting an insulin program for type 1 diabetes.
    Scheiner G
    Diabetes Self Manag; 2003; 20(5):54-6, 58. PubMed ID: 14679953
    [No Abstract]   [Full Text] [Related]  

  • 19. Intermediate and long-acting insulins: a review of NPH insulin, insulin glargine and insulin detemir.
    Peterson GE
    Curr Med Res Opin; 2006 Dec; 22(12):2613-9. PubMed ID: 17166343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Unstable type I diabetes mellitus: comparative study between intensive conventional treatment and continuous subcutaneous infusion of insulin].
    Levy I; Bergua M; Esmatjes E; Halperin I; Figuerola D
    Med Clin (Barc); 1984 Oct; 83(13):525-8. PubMed ID: 6392766
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.